The epigenetics of multiple sclerosis and other related disorders

Multiple Sclerosis and Related Disorders

Volumn 3, Issue 2, 2014, Pages 163-175

  Van Den Elsen, Peter J ^a,b   Van Eggermond, Marja C J A ^b   Puentes, Fabiola ^c   Van Der Valk, Paul ^a   Baker, David ^c   Amor, Sandra ^a,c  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Animal models; DNA methylation; Epigenetic drugs; Epigenetics; Histone modifications; Multiple sclerosis

Indexed keywords

ACETYL COENZYME A ACYLTRANSFERASE; ACYLTRANSFERASE; ARGININE; ENTINOSTAT; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEMETHYLASE; HISTONE LYSINE METHYLTRANSFERASE; LYSINE ACETYLTRANSFERASE; METHYL CPG BINDING PROTEIN 2; SIRTUIN 1; UNCLASSIFIED DRUG;

CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM; DEGENERATIVE DISEASE; DNA METHYLATION; EPIGENETIC INTERFERENCE; EPIGENETICS; EXPERIMENTAL MODEL; GENE ACTIVATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE REPRESSION; GENE SILENCING; GENE TARGETING; GENETIC TRANSCRIPTION; HISTONE ACETYLATION; HISTONE CODE; HISTONE METHYLATION; HISTONE MODIFICATION; HUMAN; HUMORAL IMMUNITY; IMMUNOPATHOGENESIS; INFLAMMATION; MACROPHAGE ACTIVATION; MULTIPLE SCLEROSIS; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; POST TRANSLATIONAL HISTONE MODIFICATION; PROTEIN FUNCTION; REVIEW; T LYMPHOCYTE; TARGET CELL;

EID: 84892830659     PISSN: 22110348     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.msard.2013.08.007     Document Type: Review

References (120)

1. T. Abel, and R.S. Zukin Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders Current Opinion in Pharmacology 8 2008 57 64
2. I.M. Adcock Histone deacetylase inhibitors as novel anti-inflammatory agents Current Opinion in Investigational Drugs 7 2006 966 973
3. D. Albani, L. Polito, A. Signorini, and G. Forloni Neuroprotective properties of resveratrol in different neurodegenerative disorders Biofactors 36 2010 370 376
4. S. Al-Izki, G. Pryce, S.J. Jackson, G. Giovannoni, and D. Baker Immunosuppression with FTY720 is insufficient to prevent secondary progressive neurodegeneration in experimental autoimmune encephalomyelitis Multiple Sclerosis 17 2011 939 948
5. F.E. Alkemade, P. Van Vliet, P. Henneman, K.W. Van Dijk, B.P. Hierck, and J.C. Van Munsteren et al. Prenatal exposure to apoE deficiency and postnatal hypercholesterolemia are associated with altered cell-specific lysine methyltransferase and histone methylation patterns in the vasculature American Journal of Pathology 176 2010 542 548
6. R.E. Amir, I.B. Van den Veyver, M. Wan, C.Q. Tran, U. Francke, and H.Y. Zoghbi Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 Nature Genetics 23 1999 185 188
7. D. Baker, W. Gerritsen, J. Rundle, and S. Amor Critical appraisal of animal models of multiple sclerosis Multiple Sclerosis 17 2011 647 657
8. D. Baker, and S. Amor Publication guidelines for refereeing and reporting on animal use in experimental autoimmune encephalomyelitis Journal of Neuroimmunology 242 2012 78 83
9. A.J. Bannister, and T. Kouzarides Regulation of chromatin by histone modifications Cell Research 21 2011 381 395
10. S.L. Berger, T. Kouzarides, R. Shiekhattar, and A. Shilatifard An operational definition of epigenetics Genes and Development 23 2009 781 783
11. B.E. Bernstein, A. Meissner, and E.S. Lander The mammalian epigenome Cell 128 2007 669 681
12. A. Bird DNA methylation patterns and epigenetic memory Genes and Development 16 2002 6 21
13. A.M. Brunner, R.Y. Tweedie-Cullen, and I.M. Mansuy Epigenetic modifications of the neuroproteome Proteomics 12 2012 2404 2420
14. L.O. Bygren, G. Kaati, and S. Edvinsson Longevity determined by paternal ancestors' nutrition during their slow growth period Acta Biotheoretica 49 2001 53 59
15. S. Camelo, A.H. Iglesias, D. Hwang, B. Due, H. Ryu, and K. Smith et al. Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis Journal of Neuroimmunology 164 2005 10 21
16. R. Cao, and Y. Zhang The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3 Current Opinion in Genetics and Development 14 2004 155 164
17. D.M. Chuang, Y. Leng, Z. Marinova, H.J. Kim, and C.T. Chiu Multiple roles of HDAC inhibition in neurodegenerative conditions Trends in Neurosciences 32 2009 591 601
18. L. Cobiac Epigenomics and nutrition Forum of Nutrition 60 2007 31 41
19. C.T. Chiu, G. Liu, P. Leeds, and D.M. Chuang Combined treatment with the mood stabilizers lithium and valproate produces multiple beneficial effects in transgenic mouse models of Huntington's disease Neuropsychopharmacology 36 2011 2406 2421
20. P.A. Cole Chemical probes for histone-modifying enzymes Nature Chemical Biology 4 2008 590 597
21. C.A. D'Souza, D.D. Wood, Y.M. She, and M.A. Moscarello Autocatalytic cleavage of myelin basic protein: an alternative to molecular mimicry Biochemistry 44 2005 12905 12913
22. J.C. De Greef, J. Wang, J. Balog, J.T. den Dunnen, R.R. Frants, and K.R. Straasheijm et al. Mutations in ZBTB24 are associated with immunodeficiency, centromeric instability, and facial anomalies syndrome type 2 American Journal of Human Genetics 88 2011 796 804
23. K.C. Dowdell, L. Pesnicak, V. Hoffmann, K. Steadman, A.T. Remaley, and J.I. Cohen et al. Valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, diminishes lymphoproliferation in the Fas -deficient MRL/lpr(-/-) murine model of autoimmune lymphoproliferative syndrome (ALPS) Experimental Hematology 37 2009 487 494
24. G.C. Ebers, D.E. Bulman, A.D. Sadovnick, D.W. Paty, S. Warren, and W. Hader et al. A population-based study of multiple sclerosis in twins New England Journal of Medicine 315 1986 1638 1642
25. K.S. Egorova, O.M. Olenkina, and L.V. Olenina Lysine methylation of nonhistone proteins is a way to regulate their stability and function Biochemistry (Mosc) 75 2010 535 548
26. C. Fenoglio, E. Ridolfi, D. Galimberti, and E. Scarpini MicroRNAs as active players in the pathogenesis of multiple sclerosis International Journal of Molecular Sciences 13 2012 13227 13239
27. D.L. Foley, J.M. Craig, R. Morley, C.J. Olsson, T. Dwyer, and K. Smith et al. Prospects for epigenetic epidemiology American Journal of Epidemiology 169 2009 389 400
28. M.F. Fraga, E. Ballestar, M.F. Paz, S. Ropero, F. Setien, and M.L. Ballestar et al. Epigenetic differences arise during the lifetime of monozygotic twins Proceedings of the National Academy of Sciences of the United States of America 102 2005 10604 10609
29. F. Fuks, P.J. Hurd, D. Wolf, X. Nan, A.P. Bird, and T. Kouzarides The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation Journal of Biological Chemistry 278 2003 4035 4040
30. A. Fuso The 'golden age' of DNA methylation in neurodegenerative diseases Clinical Chemistry and Laboratory Medicine 51 2013 523 534
31. M. Garcia-Dominguez, and J.C. Reyes SUMO association with repressor complexes, emerging routes for transcriptional control Biochimica et Biophysica Acta 1789 2009 451 459
32. Z. Ge, Y. Da, Z. Xue, K. Zhang, H. Zhuang, and M. Peng et al. Vorinostat, a histone deacetylase inhibitor, suppresses dendritic cell function and ameliorates experimental autoimmune encephalomyelitis Experimental Neurology 241 2013 56 66
33. S.J. Gobin, L. Montagne, M. Van Zutphen, P. Van der Valk, P.J. Van den Elsen, and C.J. De Groot Upregulation of transcription factors controlling MHC expression in multiple sclerosis lesions Glia 36 2001 68 77
34. C. Guerrero-Bosagna, and M.K. Skinner Environmentally induced epigenetic transgene rational inheritance of phenotype and disease Molecular and Cellular Endocrinology 354 2012 3 8
35. A.E. Handel, G. Giovannoni, G.C. Ebers, and S.V. Ramagopalan Environmental factors and their timing in adult-onset multiple sclerosis Nature Reviews Neurology 6 2010 156 166
36. E. Hockly, V.M. Richon, B. Woodman, D.L. Smith, X. Zhou, and E. Rosa et al. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model ofHuntington's disease Proceedings of the National Academy of Sciences of the United States of America 100 2003 2041 2046
37. J.L. Huynh, and P. Casaccia Epigenetic mechanisms in multiple sclerosis: implications for pathogenesis and treatment Lancet Neurology 12 2013 195 206
38. R.A. Irizarry, C. Ladd-Acosta, B. Wen, Z. Wu, C. Montano, and P. Onyango et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores Nature Genetics 41 2009 178 186
39. R. Jaenisch, and A. Bird Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals Nature Genetics 33 Suppl 2003 245 254
40. T. Jenuwein, and C.D. Allis Translating the histone code Science 293 2001 1074 1080
41. F. Jin, Q. Wu, Y.F. Lu, Q.H. Gong, and J.S. Shi Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats European Journal of Pharmacology 600 2008 78 82
42. A. Junker, M. Krumbholz, S. Eisele, H. Mohan, F. Augstein, and R. Bittner et al. MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47 Brain 132 2009 3342 3352
43. A. Junker, R. Hohlfeld, and E. Meinl The emerging role of microRNAs in multiple sclerosis Nature Reviews Neurology 7 2011 56 59
44. G. Kaati, L.O. Bygren, and S. Edvinsson Cardiovascular and diabetes mortality determined by nutrition during parents' and grandparents' slow growth period European Journal of Human Genetics 10 2002 682 688
45. Z.A. Kaminsky, T. Tang, S.C. Wang, C. Ptak, G.H. Oh, and A.H. Wong et al. DNA methylation profiles in monozygotic and dizygotic twins Nature Genetics 41 2009 240 245
46. S. Kangaspeska, B. Stride, R. Metivier, M. Polycarpou-Schwarz, D. Ibberson, and R.P. Carmouche et al. Transient cyclical methylation of promoter DNA Nature 452 2008 112 115
47. A. Keller, P. Leidinger, J. Lange, A. Borries, H. Schroers, and M. Scheffler et al. Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls PLoS One 4 2009 e7440
48. M. Kilgore, C.A. Miller, D.M. Fass, K.M. Hennig, S.J. Haggarty, and J.D. Sweatt et al. Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer's disease Neuropsychopharmacology 35 2010 870 880
49. J.K. Kim, M. Samaranayake, and S. Pradhan Epigenetic mechanisms in mammals Cellular and Molecular Life Sciences 66 2009 596 612
50. K.S. Kobayashi, and P.J. van den Elsen NLRC5: a key regulator of MHC class I-dependent immune responses Nature Reviews Immunology 12 2012 813 820
51. M.W. Koch, L.M. Metz, and O. Kovalchuk Epigenetic changes in patients with multiple sclerosis Nature Reviews Neurology 9 2013 35a 43a
52. M.W. Koch, L.M. Metz, and O. Kovalchuk Epigenetics and miRNAs in the diagnosis and treatment of multiple sclerosis Trends in Molecular Medicine 19 2013 23b 30b
53. M.S. Kortenhorst, M.A. Carducci, and S. Shabbeer Acetylation and histone deacetylase inhibitors in cancer Cellular Oncology 28 2006 191 222
54. T. Kouzarides Chromatin modifications and their function Cell 128 2007 693 705
55. J. Kragt, B. van Amerongen, J. Killestein, C. Dijkstra, B. Uitdehaag, and Ch. Polman et al. Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women Multiple Sclerosis 15 2009 9 15
56. M. Kulis, and M. Esteller DNA methylation and cancer Advances in Genetics 70 2010 27 56
57. J.F. Kurtzke Multiple sclerosis in time and space - geographic clues to cause Journal of Neurovirology 6 2000 S134 S140
58. M. Lalande, and M.A. Calciano Molecular epigenetics of Angelman syndrome Cellular and Molecular Life Sciences 64 2007 947 960
59. B. Li, M. Carey, and J.L. Workman The role of chromatin during transcription Cell 128 2007 707 719
60. H. Li, Y. He, W.D. Richardson, and P. Casaccia Two-tier transcriptional control of oligodendrocyte differentiation Current Opinion in Neurobiology 19 2009 479 485
61. T. Li, M.J. Morgan, S. Choksi, Y. Zhang, Y.S. Kim, and Z.G. Liu MicroRNAs modulate the noncanonical transcription factor NF-kappaB pathway by regulating expression of the kinase IKKalpha during macrophage differentiation Nature Immunology 11 2010 799 805
62. J.S. Li, and Z.X. Yao MicroRNAs: novel regulators of oligodendrocyte differentiation and potential therapeutic targets in demyelination-related diseases Molecular Neurobiology 45 2012 200 212
63. G.P. Lim, T. Chu, F. Yang, W. Beech, S.A. Frautschy, and G.M. Cole The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse Journal of Neuroscience 21 2001 8370 8377
64. S. Lim, A.S. Chesser, J.C. Grima, P.M. Rappold, D. Blum, and S. Przedborski Tieu KD-β-hydroxybutyrate is protective in mouse models of Huntington's disease PLoS One 6 2011 e24620
65. H.S. Lin, C.Y. Hu, H.Y. Chan, Y.Y. Liew, H.P. Huang, and L. Lepescheux et al. Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents British Journal of Pharmacology 150 2007 862 872
66. Z. Long, M. Zheng, L. Zhao, P. Xie, C. Song, and Y. Chu et al. Valproic acid attenuates neuronal loss in the brain of APP/PS1 double transgenic Alzheimer's diseasemice model Current Alzheimer Research 10 2013 261 269
67. K. Luger, A.W. Mader, R.K. Richmond, D.F. Sargent, and T.J. Richmond Crystal structure of the nucleosome core particle at 2.8 A resolution Nature 389 1997 251 260
68. A. Mai The therapeutic uses of chromatin-modifying agents Expert Opinion on Therapeutic Targets 11 2007 835 851
69. C. Martin, and Y. Zhang The diverse functions of histone lysine methylation Nature Reviews Molecular Cell Biology 6 2005 838 849
70. F.G. Mastronardi, A. Noor, D.D. Wood, T. Paton, and M.A. Moscarello Peptidyl argininedeiminase 2 CpG island in multiple sclerosis white matter is hypomethylated Journal of Neuroscience Research 85 2007 2006 2016
71. R. Metivier, R. Gallais, C. Tiffoche, P.C. Le, R.Z. Jurkowska, and R.P. Carmouche et al. Cyclical DNA methylation of a transcriptionally active promoter Nature 452 2008 45 50
72. M.A. Moscarello, F.G. Mastronardi, and D.D. Wood The role of citrullinated proteins suggests a novel mechanism in the pathogenesis of multiple sclerosis Neurochemical Research 32 2007 251 256
73. Y. Nasu, K. Nishida, S. Miyazawa, T. Komiyama, Y. Kadota, and N. Abe et al. Trichostatin A, a histone deacetylase inhibitor, suppresses synovial inflammation and subsequent cartilage destruction in a collagen antibody-induced arthritis mouse model Osteoarthritis and Cartilage 16 2008 723 732
74. M. Niino, T. Fukazawa, S. Kikuchi, and H. Sasaki Therapeutic potential of vitamin D for multiple sclerosis Current Medicinal Chemistry 15 2008 499 505
75. H. Noh, E.Y. Oh, J.Y. Seo, M.R. Yu, Y.O. Kim, and H. Ha et al. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury American Journal of Physiology - Renal Physiology 297 2009 F729 F739
76. F. Noorbakhsh, K.K. Ellestad, F. Maingat, K.G. Warren, M.H. Han, and L. Steinman et al. Impaired neurosteroid synthesis in multiple sclerosis Brain 134 2011 2703 2721
77. J. Pakpoor, G. Giovannoni, and S.V. Ramagopalan Epstein-Barr virus and multiple sclerosis: association or causation? Expert Review of Neurotherapeutics 13 2013 287 297
78. N.A. Patsopoulos, F. Esposito, J. Reischl, S. Lehr, D. Bauer, and J. Heubach et al. Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci Annals of Neurology 70 2011 897 912
79. X. Pedre, F. Mastronardi, W. Bruck, G. López-Rodas, T. Kuhlmann, and P. Casaccia Changed histone acetylation patterns in normal-appearing white matter and early multiple sclerosis lesions Journal of Neuroscience 31 2011 3435 3445
80. M.E. Pembrey, L.O. Bygren, G. Kaati, S. Edvinsson, K. Northstone, and M. Sjöström et al. ALSPAC Study Team. Sex-specific, male-line transgenerational responses in humans European Journal of Human Genetics 14 2006 159 166
81. F. Petrij, R.H. Giles, H.G. Dauwerse, J.J. Saris, R.C. Hennekam, and M. Masuno et al. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP Nature 376 1995 348 351
82. H. Qing, G. He, P.T. Ly, C.J. Fox, M. Staufenbiel, and F. Cai et al. Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models Journal of Experimental Medicine 205 2008 2781 2789
83. A. Rajeswari, and M. Sabesan Inhibition of monoamine oxidase-B by the polyphenolic compound, curcumin and its metabolite tetrahydrocurcumin, in a model of Parkinson's disease induced by MPTP neurodegeneration in mice Inflammopharmacology 16 2008 96 99
84. J.C. Rice, S.D. Briggs, B. Ueberheide, C.M. Barber, J. Shabanowitz, and D.F. Hunt et al. Histone methyltransferases direct different degrees of methylation to define distinct chromatin domains Molecular Cell 12 2003 1591 1598
85. S.J. Saouaf, B. Li, G. Zhang, Y. Shen, N. Furuuchi, and W.W. Hancock et al. Deacetylase inhibition increases regulatory T cell function and decreases incidence and severity of collagen-induced arthritis Experimental and Molecular Pathology 87 2009 99 104
86. F. Sato, S. Tsuchiya, S.J. Meltzer, and K. Shimizu MicroRNAs and epigenetics FEBS Journal 278 2011 1598 1609
87. S. Sawcer, G. Hellenthal, M. Pirinen, C.C. Spencer, N.A. Patsopoulos, and L. Moutsianas et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis Nature 476 2011 214 219
88. G. Schotta, M. Lachner, K. Sarma, A. Ebert, R. Sengupta, and G. Reuter et al. A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin Genes and Development 18 2004 1251 1262
89. S. Shen, J. Sandoval, V.A. Swiss, J. Li, J. Dupree, and R.J. Franklin et al. Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency Nature Neuroscience 11 2008 1024 1034
90. K.S. Shindler, E. Ventura, T.S. Rex, P. Elliot, and A. Rostami SIRT1 activation confers neuroprotection in experimental optic neuritis Investigative Ophthalmology and Visual Science 48 2007 3602 3609
91. K.S. Shindler, E. Ventura, M. Dutt, P. Elliott, D.C. Fitzgerald, and A. Rostami Oral resveratrol reduces neuronal damage in a model of multiple sclerosis Journal of Neuroophthalmology 30 2010 328 339
92. A. Shukla, P. Chaurasia, and S.R. Bhaumik Histone methylation and ubiquitination with their cross-talk and roles in gene expression and stability Cellular and Molecular Life Sciences 66 2009 1419 1433
93. J. Smolders, J. Damoiseaux, P. Menheere, and R. Hupperts Vitamin D as an immune modulator in multiple sclerosis, a review Journal of Neuroimmunology 194 2008 7 17
94. B.D. Strahl, and C.D. Allis The language of covalent histone modifications Nature 403 2000 41 45
95. K. Struhl Histone acetylation and transcriptional regulatory mechanisms Genes and Development 12 1998 599 606
96. D. Takai, and P.A. Jones Comprehensive analysis of CpG islands in human chromosomes 21 and 22 Proceedings of the National Academy of Sciences of the United States of America 99 2002 3740 3745
97. Q. Tao, and K.D. Robertson Stealth technology: how Epstein-Barr virus utilizes DNA methylation to cloak itself from immune detection Clinical Immunology 109 2003 53 63
98. M. Thamilarasan, D. Koczan, M. Hecker, B. Paap, and U.K. Zettl MicroRNAs in multiple sclerosis and experimental autoimmune encephalomyelitis Autoimmunity Reviews 11 2012 174 179
99. R.G. Urdinguio, J.V. Sanchez-Mut, and M. Esteller Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies Lancet Neurology 8 2009 1056 1072
100. P.J. Van den Elsen, T.M. Holling, H.F. Kuipers, and N. Van der Stoep Transcriptional regulation of antigen presentation Current Opinion in Immunology 16 2004 67 75
101. B.J. Van der Star, D.Y. Vogel, M. Kipp, F. Puentes, D. Baker, and S. Amor In vitro and in vivo models of multiple sclerosis CNS and Neurological Disorders - Drug Targets 11 2012 570 588
102. P. Van der Valk, and S. Amor Preactive lesions in multiple sclerosis Current Opinion in Neurology 22 2009 207 213
103. T. Vaissiere, C. Sawan, and Z. Herceg Epigenetic interplay between histone modifications and DNA methylation in gene silencing Mutation Research 659 2008 40 48
104. E. Vire, C. Brenner, R. Deplus, L. Blanchon, M. Fraga, and C. Didelot et al. The Polycomb group protein EZH2 directly controls DNA methylation Nature 439 2006 871 874
105. G.G. Wang, C.D. Allis, and P. Chi Chromatin remodeling and cancer, Part I: covalent histone modifications Trends in Molecular Medicine 13 2007 363 372
106. P. Wang, C. Lin, E.R. Smith, H. Guo, B.W. Sanderson, and M. Wu et al. Global analysis of H3K4 methylation defines MLL family member targets and points to a role for MLL1-mediated H3K4 methylation in the regulation of transcriptional initiation by RNA polymerase II Molecular and Cellular Biology 29 2009 6074 6085
107. I.C. Weaver, N. Cervoni, F.A. Champagne, A.C. D'Alessio, S. Sharma, and J.R. Seckl et al. Epigenetic programming by maternal behavior Nature Neuroscience 7 2004 847 854
108. I.C. Weaver, M.J. Meaney, and M. Szyf Maternal care effects on the hippocampal transcriptome and anxiety-mediated behaviors in the offspring that are reversible in adulthood Proceedings of the National Academy of Sciences of the United States of America 103 2006 3480 3485
109. C.M.R. Weemaes, M.J.D. Van Tol, J. Wang, M.M. Van Ostaijen-ten Dam, M.C.J.A. Van Eggermond, and C. Aytekin et al. Heterogeneous clinical presentation in ICF syndrome: correlation with underlying gene defects European Journal of Human Genetics 2013 10.1038/ejhg.2013.40 ([Epub ahead of print])
110. R.J. Wierda, S.B. Geutskens, P.H.A. Quax, J.W. Jukema, and P.J. Van den Elsen Epigenetics in atherosclerosis and inflammation Journal of Cellular and Molecular Medicine 14 2010 1225 1240
111. K. Williams, J. Christensen, and K. Helin DNA methylation: TET proteins-guardians of CpG islands? EMBO Reports 13 2012 28 35
112. L. Xie, X.K. Li, N. Funeshima-Fuji, H. Kimura, Y. Matsumoto, and Y. Isaka et al. Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production International Immunopharmacology 9 2009 575 581
113. G.L. Xu, T.H. Bestor, D. Bourc'his, C.L. Hsieh, N. Tommerup, and M. Bugge et al. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene Nature 402 1999 187 191
114. C. Yan, and D.D. Boyd Histone H3 acetylation and H3 K4 methylation define distinct chromatin regions permissive for transgene expression Molecular and Cellular Biology 26 2006 6357 6371
115. Y.L. Yao, and W.M. Yang Beyond histone and deacetylase: an overview of cytoplasmic histone deacetylases and their nonhistone substrates Journal of Biomedicine and Biotechnology 2011 2011 146493
116. Z. Zhang, Z.Y. Zhang, U. Fauser, and H.J. Schluesener Valproic acid attenuates inflammation in experimental autoimmune neuritis Cellular and Molecular Life Sciences 65 2008 4055 4065
117. Z.Y. Zhang, Z. Zhang, and H.J. Schluesener MS-275 an histone deacetylase inhibitor, reduces the inflammatory reaction in rat experimental autoimmune neuritis Neuroscience 169 2010 370 377
118. Z. Zhang, Z.Y. Zhang, Y. Wu, and H.J. Schluesener Valproic acid ameliorates inflammation in experimental autoimmune encephalomyelitis rats Neuroscience 221 2012 140 150
119. Z.Y. Zhang, and H.J. Schluesener HDAC inhibitor MS-275 attenuates the inflammatory reaction in rat experimental autoimmune prostatitis Prostate 72 2012 90 99
120. Z.Y. Zhang, and H.J. Schluesener Oral administration of histone deacetylase inhibitor MS-275 ameliorates neuroinflammation and cerebral amyloidosis and improves behavior in a mouse model Journal of Neuropathology and Experimental Neurology 72 2013 178 185